|
| 35274303 | Antibodies against biotin-labeled red blood cells can shorten posttransfusion survival. | Transfusion | 2022 |
| 31340188 | Target-mediated disposition population pharmacokinetics model of erythropoietin in premature neonates following multiple intravenous and subcutaneous dosing regimens. | Eur J Pharm Sci | 2019 |
| 29193118 | In premature infants there is no decrease in 24-hour posttransfusion allogeneic red blood cell recovery after 42 days of storage. | Transfusion | 2018 |
| 30478521 | Overlooked Issues on Pharmacokinetics Data Interpretation of Protein Drugs-a Case Example of Erythropoietin. | AAPS J | 2018 |
| 29770455 | Development, validation, and potential applications of biotinylated red blood cells for posttransfusion kinetics and other physiological studies: evidenced-based analysis and recommendations. | Transfusion | 2018 |
| 27450367 | Leigh-Like Syndrome Due to Homoplasmic m.8993T>G Variant with Hypocitrullinemia and Unusual Biochemical Features Suggestive of Multiple Carboxylase Deficiency (MCD). | JIMD Rep | 2017 |
| 28189627 | Population Pharmacokinetics of Darbepoetin in Infants Following Single Intravenous and Subcutaneous Dosing. | J Pharm Sci | 2017 |
| 28099421 | Estimation of adult and neonatal RBC lifespans in anemic neonates using RBCs labeled at several discrete biotin densities. | Pediatr Res | 2017 |
| 28261808 | Antibodies to biotinylated red blood cells in adults and infants: improved detection, partial characterization, and dependence on red blood cell-biotin dose. | Transfusion | 2017 |
| 29076057 | Erratum: Leigh-Like Syndrome Due to Homoplasmic m.8993T>G Variant with Hypocitrullinemia and Unusual Biochemical Features Suggestive of Multiple Carboxylase Deficiency (MCD). | JIMD Rep | 2017 |
| 28701385 | Biotin: From Nutrition to Therapeutics. | J Nutr | 2017 |
| 26699811 | Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis. | Expert Opin Drug Metab Toxicol | 2016 |
| 26327679 | Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis. | Neuropharmacology | 2016 |
| 26502725 | A Mass Balance-Based Semiparametric Approach to Evaluate Neonatal Erythropoiesis. | AAPS J | 2016 |
| 27215601 | A Novel Physiology-Based Mathematical Model to Estimate Red Blood Cell Lifespan in Different Human Age Groups. | AAPS J | 2016 |
| 27040455 | Clearance of stored red blood cells is not increased compared with fresh red blood cells in a human endotoxemia model. | Transfusion | 2016 |
| 27039311 | Models for the red blood cell lifespan. | J Pharmacokinet Pharmacodyn | 2016 |
| 25527659 | In HepG2 cells, coexisting carnitine deficiency masks important indicators of marginal biotin deficiency. | J Nutr | 2015 |
| 26363547 | Autologous Infant and Allogeneic Adult Red Cells Demonstrate Similar Concurrent Post-Transfusion Survival in Very Low Birth Weight Neonates. | J Pediatr | 2015 |
| 26017162 | A Method to Evaluate Fetal Erythropoiesis from Postnatal Survival of Fetal RBCs. | AAPS J | 2015 |
| 24969019 | Measurement of posttransfusion red cell survival with the biotin label. | Transfus Med Rev | 2014 |
| 25320191 | Adequate intake of biotin in pregnancy: why bother? | J Nutr | 2014 |
| 24088873 | Comparison of multiple red cell volume methods performed concurrently in premature infants following allogeneic transfusion. | Pediatr Res | 2013 |
| 24108188 | Tracking donor RBC survival in premature infants: agreement of multiple populations of biotin-labeled RBCs with Kidd antigen-mismatched RBCs. | Pediatr Res | 2013 |
| 22157538 | Marginal biotin deficiency can be induced experimentally in humans using a cost-effective outpatient design. | J Nutr | 2012 |
| 22780899 | Posttransfusion red blood cell (RBC) survival determined using biotin-labeled RBCs has distinct advantages over labeling with (51) Cr. | Transfusion | 2012 |
| 22833654 | Measurement of acylcarnitine substrate to product ratios specific to biotin-dependent carboxylases offers a combination of indicators of biotin status in humans. | J Nutr | 2012 |
| 22229348 | Comparison of red blood cell survival in sheep determined using red blood cells labeled with either biotin at multiple densities or [14C]cyanate: validation of a model to study human physiology and disease. | Transfusion | 2012 |
| 22023312 | Accelerated removal of antibody-coated red blood cells from the circulation is accurately tracked by a biotin label. | Transfusion | 2012 |
| 20630041 | Red blood cell (RBC) volume can be independently determined in vivo in humans using RBCs labeled at different densities of biotin. | Transfusion | 2011 |
| 21918059 | Urinary excretion of 3-hydroxyisovaleric acid and 3-hydroxyisovaleryl carnitine increases in response to a leucine challenge in marginally biotin-deficient humans. | J Nutr | 2011 |
| 21892638 | Measurement of 3-hydroxyisovaleric acid in urine from marginally biotin-deficient humans by UPLC-MS/MS. | Anal Bioanal Chem | 2011 |
| 21905207 | In vivo multispectral photoacoustic and photothermal flow cytometry with multicolor dyes: a potential for real-time assessment of circulation, dye-cell interaction, and blood volume. | Cytometry A | 2011 |
| 21051254 | Development and characterization of a mouse with profound biotinidase deficiency: a biotin-responsive neurocutaneous disorder. | Mol Genet Metab | 2011 |
| 21062290 | Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities. | Transfusion | 2011 |
| 21248194 | Urinary excretion of 3-hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans. | J Nutr | 2011 |
| 20397702 | Quantitative measurement of plasma 3-hydroxyisovaleryl carnitine by LC-MS/MS as a novel biomarker of biotin status in humans. | Anal Chem | 2010 |
| 20943794 | Plasma concentration of 3-hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans. | Am J Clin Nutr | 2010 |
| 21028833 | Quantitative measurement of urinary excretion of 3-hydroxyisovaleryl carnitine by LC-MS/MS as an indicator of biotin status in humans. | Anal Chem | 2010 |
| 20561297 | Red blood cell (RBC) volume can be independently determined in vivo in the sheep using ovine RBCs labeled at different densities of biotin. | Transfusion | 2010 |
| 19056638 | Introduction to "Advances in understanding of the biological role of biotin at the clinical, biochemical, and molecular level". | J Nutr | 2009 |
| 19220818 | Red blood cell volume can be independently determined in vitro using sheep and human red blood cells labeled at different densities of biotin. | Transfusion | 2009 |
| 19056637 | Marginal biotin deficiency is common in normal human pregnancy and is highly teratogenic in mice. | J Nutr | 2009 |
| 18194383 | A randomized clinical trial comparing immediate versus delayed clamping of the umbilical cord in preterm infants: short-term clinical and laboratory endpoints. | Transfusion | 2008 |
| 18996865 | Biotin accounts for less than half of all biotin and biotin metabolites in the cerebrospinal fluid of children. | Am J Clin Nutr | 2008 |
| 18974016 | Management of a patient with holocarboxylase synthetase deficiency. | Mol Genet Metab | 2008 |
| 18541968 | Biotin-sensitive 3-methylcrotonylglycinuria in a patient with severe growth delay, ectodermal abnormalities, neonatal progeroid appearance, and developmental delay. | Clin Dysmorphol | 2008 |
| 18596580 | Red cell volume can be accurately determined in sheep using a nonradioactive biotin label. | Pediatr Res | 2008 |
| 18287661 | Biotin-protein bond: instability and structural modification to provide stability for in vivo applications. | Methods Mol Biol | 2008 |
| 16895887 | Lymphocyte propionyl-CoA carboxylase and its activation by biotin are sensitive indicators of marginal biotin deficiency in humans. | Am J Clin Nutr | 2006 |